An epitope-focused nanoparticle vaccine for mrsa and biodefense
Ended Project Grant Awarded Last action
- Award ID
- R41AI122594
- Recipient
-
VLP Biotech, Inc. UEI JPNRGENTXC35
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $546,129
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- San Diego, CA 92121, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $272,381 | |
| Amendment | -$8,586 | |
| Original award | $282,334 |
Quick answers
Who received award R41AI122594?
R41AI122594 was awarded to VLP Biotech, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 15, 2016.
How much is award R41AI122594 worth?
$546,129 has been obligated on R41AI122594.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award